Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

8 Aug 2007 16:58

ReNeuron Group plc08 August 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer RENEURON GROUP PLC 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) A TRANSACTION NOTIFIED IN ACCORDANCE WITH DR 3.1.4R(1)(A). 3. Name of person discharging managerial responsibilities/director JOHN SINDEN - DIRECTOR 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest(1) 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them 8. State the nature of the transaction 9. Number of shares, debentures or financial instruments relating to shares acquired 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 11. Number of shares, debentures or financial instruments relating to shares disposed 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 13. Price per share or value of transaction 14. Date and place of transaction 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 16. Date issuer informed of transaction If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant 7 AUGUST 2007 18. Period during which or date on which it can be exercised 10 YEARS FROM THE 7 AUGUST 2007 SUBJECT TO PERFORMANCE CONDITIONS 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 1,000,000 ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise 500,000 ORDINARY SHARES AT AN EXERCISE PRICE OF 21 PENCE PER SHARE; AND 500,000 ORDINARY SHARES AT AN EXERCISE PRICE OF 37.5 PENCE PER SHARE. 22. Total number of shares or debentures over which options held following notification 3,396,680 ORDINARY SHARES (INCLUDING ALL PREVIOUS OPTIONS) 23. Any additional information GRANTED UNDER THE RULES OF THE EMPLOYEE SHARE OPTION SCHEME 24. Name of contact and telephone number for queries MICHAEL HUNT CHIEF EXECUTIVE OFFICER PH: +44(0) 1483302560 Name and signature of duly authorised officer of issuer responsible for making notification Date of notification 8/8/07 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Feb 20167:00 amRNSNotice of Grant of Key US Patent
12th Jan 20167:00 amRNSPre-clinical data relating to exosome platform
11th Jan 20167:00 amRNSWins UK grant to advance its exosome platform
17th Dec 20157:00 amRNSReNeuron establishes Scientific Advisory Board
7th Dec 20157:00 amRNSInterim Results
4th Dec 20157:00 amRNSNon-executive Director appointment
12th Nov 20152:45 pmRNSNotification of Interim Results
6th Nov 20153:29 pmRNSTotal Voting Rights
2nd Oct 20153:01 pmRNSDirectors' Interest in Shares and Share Options
28th Sep 201512:18 pmRNSBlock Admission and Total Voting Rights
24th Sep 20151:50 pmRNSResult of AGM
24th Sep 20157:00 amRNSAGM Trading Update
1st Sep 20153:22 pmRNSNotification of Major Interest in Shares
28th Aug 20152:45 pmRNSNotification of Major Interest in Shares
28th Aug 20157:00 amRNSNotification of Major Interest in Shares
27th Aug 20157:01 amRNSNotification of Major Interest in Shares
26th Aug 20157:30 amRNSNotification of Major Interest in Shares
26th Aug 20157:00 amRNSPosting of Annual Report and Notice of AGM
25th Aug 201510:00 amRNSCompletion of Placing and TVR
21st Aug 20151:45 pmRNSResult of General Meeting
29th Jul 20154:14 pmRNSPublication of Circular and Notice of GM
10th Jul 20157:01 amRNSPlacing to Raise £68.4 million
10th Jul 20157:00 amRNSPreliminary Results
22nd Jun 20157:00 amRNSExosome Research Collaboration
11th Jun 20157:00 amRNSSenior Management Appointments
29th May 20153:00 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd May 20157:00 amRNSFDA Grants Fast Track Designation
15th May 20157:00 amRNSNotification of Major Interest in Shares
7th May 20157:00 amRNSNotification of Major Interest in Shares
5th May 20157:01 amRNSFDA Approves Start of Phase I/II Trial
22nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20154:35 pmRNSPrice Monitoring Extension
17th Apr 201512:15 pmRNSLong Term Clinical Data from PISCES Stroke Trial
13th Apr 20157:00 amRNSIND in the US
1st Apr 20157:00 amRNSReconfigures Board and Strengthens Executive Team
30th Jan 20157:00 amRNSDirector Share Purchases
13th Jan 20153:28 pmRNSNotification of Major Interest in Shares
8th Jan 20152:46 pmRNSNotification of Major Interest in Shares
17th Nov 20147:00 amRNSInterim Results
30th Oct 20147:00 amRNSNotification of Interim Results
14th Oct 20147:00 amRNSNotification of Major Interest in Shares
22nd Sep 20147:00 amRNSDirectors' Interest in Shares and Share Options
15th Sep 201412:15 pmRNSBlock Listing Six Monthly Review
8th Sep 20147:00 amRNSAppointment of CEO
3rd Sep 20147:00 amRNSNotification of Major Interest in Shares
2nd Sep 201411:30 amRNSResult of 2014 Annual General Meeting
2nd Sep 20147:00 amRNSAGM Trading Update
19th Aug 20149:00 amRNSNotification of Major Interest in Shares
25th Jul 20149:59 amRNSDirector/PDMR Shareholding
17th Jul 20149:00 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.